Cargando…

Protective and dysregulated T cell immunity in RSV infection()

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and a major pathogen in elderly and immunosuppressed persons. Although RSV shows limited antigenic diversity, repeated infections occur throughout life. Vaccine development has been delayed by poor immunogenicit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Openshaw, Peter J, Chiu, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295022/ https://www.ncbi.nlm.nih.gov/pubmed/23806514 http://dx.doi.org/10.1016/j.coviro.2013.05.005

Ejemplares similares

Immunity to RSV in Early-Life
por: Lambert, Laura, et al.
Publicado: (2014)

A Gene Expression Signature for RSV: Clinical Implications and Limitations
por: Openshaw, Peter J. M.
Publicado: (2013)

Resilience of the respiratory microbiome in controlled adult RSV challenge study
por: Cuthbertson, Leah, et al.
Publicado: (2022)

Antiviral B cell and T cell immunity in the lungs
por: Chiu, Christopher, et al.
Publicado: (2014)

Alterations in RSV induced pulmonary illness due to mutations in the attachment protein G
por: Sparer, T., et al.
Publicado: (1997)

Erratum: Airway T cells protect against RSV infection in the absence of antibody
por: Kinnear, E, et al.
Publicado: (2017)

A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection
por: Endt, Kathrin, et al.
Publicado: (2022)

The assessment of future RSV immunizations: How to protect all infants?
por: Bont, Louis, et al.
Publicado: (2022)

Toward unified molecular surveillance of RSV: A proposal for genotype definition
por: Goya, Stephanie, et al.
Publicado: (2020)

RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection
por: Jozwik, Agnieszka, et al.
Publicado: (2015)

RSV Vaccine Based on Rhabdoviral Vector Protects after Single Immunization
por: Wilmschen, Sarah, et al.
Publicado: (2019)

Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018)

Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants
por: Wilkins, Deidre, et al.
Publicado: (2023)

Epitope-specific airway-resident CD4(+) T cell dynamics during experimental human RSV infection
por: Guvenel, Aleks, et al.
Publicado: (2019)

The Chemokine MIP1α/CCL3 Determines Pathology in Primary RSV Infection by Regulating the Balance of T Cell Populations in the Murine Lung
por: Tregoning, John S., et al.
Publicado: (2010)

Erratum: RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection
por: Jozwik, Agnieszka, et al.
Publicado: (2016)

Endogenous IL-21 regulates pathogenic mucosal CD4 T-cell responses during enhanced RSV disease in mice
por: Dodd, J S, et al.
Publicado: (2013)

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
por: Cox, Freek, et al.
Publicado: (2023)

An outbreak of RSV infections in a neonatology clinic during the RSV-season
por: Vakrilova, Liliya, et al.
Publicado: (2021)

Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV
por: Nederend, Maaike, et al.
Publicado: (2020)

Human T cells efficiently control RSV infection
por: De, Chandrav, et al.
Publicado: (2023)

Maternal gut microbiome regulates immunity to RSV infection in offspring
por: Fonseca, Wendy, et al.
Publicado: (2021)

Increased Lung Catalase Activity Confers Protection Against Experimental RSV Infection
por: Ansar, Maria, et al.
Publicado: (2020)

Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity
por: Maier, Clara, et al.
Publicado: (2022)

An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization
por: Raghunandan, Rama, et al.
Publicado: (2014)

Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients
por: Ye, Xunyan, et al.
Publicado: (2021)

RSV: perspectives to strengthen the need for protection in all infants
por: Navarro Alonso, Jose Antonio, et al.
Publicado: (2021)

Global molecular diversity of RSV – the “INFORM RSV” study
por: Langedijk, Annefleur C., et al.
Publicado: (2020)

RSV infection does not induce EMT
por: Talukdar, Sattya N., et al.
Publicado: (2023)

M Protein-Deficient Respiratory Syncytial Virus (RSV) Vaccine Protects Infant Baboons Against RSV Challenge
por: Welliver, Robert C, et al.
Publicado: (2017)

Strategies for active and passive pediatric RSV immunization
por: Eichinger, Katherine M., et al.
Publicado: (2021)

Obesity dysregulates the pulmonary antiviral immune response
por: Almond, Mark, et al.
Publicado: (2023)

Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal()
por: Chu, Helen Y., et al.
Publicado: (2017)

Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents
por: Umemoto, Shingo, et al.
Publicado: (2023)

131. The Protective Role of Mucosal Interferons in Infants with Respiratory Syncytial Virus (RSV) Infection
por: Taveras, Jeanette, et al.
Publicado: (2020)

Chimeric Measles Virus (MV/RSV), Having Ectodomains of Respiratory Syncytial Virus (RSV) F and G Proteins Instead of Measles Envelope Proteins, Induced Protective Antibodies against RSV
por: Sawada, Akihito, et al.
Publicado: (2021)

Progressive Changes in Inflammatory and Matrix Adherence of Bronchial Epithelial Cells with Persistent Respiratory Syncytial Virus (RSV) Infection (Progressive Changes in RSV Infection)
por: Liu, Xiaoai, et al.
Publicado: (2013)

Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates
por: Pierantoni, Angiolo, et al.
Publicado: (2015)

Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model
por: Fuentes, Sandra, et al.
Publicado: (2017)

A model for respiratory syncytial virus (RSV) infection based on experimental aerosol exposure with bovine RSV in calves
por: Otto, P., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_i0a52fr1ip1vfdk9u7qk2np3ag